Suggestions
Nicholas Goldner, PhD
Founder and CMO @ resistanceBio | Solving Cancer Resistance
Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, a company developing novel therapies targeting cancer treatment resistance mechanisms.1 He is not the CMO as stated in the query, but rather the CEO. Goldner is an entrepreneur and molecular biologist focused on defeating cancer, driven by a personal connection.2
Goldner's professional experience includes:
- CEO and co-founder of resistanceBio (March 2021 - Present)1
- Venture Partner at Pioneer Fund (October 2020 - Present)1
- Former CEO and co-founder of Viosera Therapeutics (July 2016 - January 2022)1
His educational background comprises:
- PhD in Molecular Cell Biology from Washington University in St. Louis1
- BS in Biochemistry from Wisconsin Lutheran College1
- Participation in Y Combinator1
At resistanceBio, Goldner has developed the ResCu system, a proprietary cancer culture system that predicts resistance mechanisms to therapies.2 His work aims to map the cancer resistome and develop smarter cancer therapies and diagnostics.2
Highlights
May 4 · pmwcintl.com
Nick Goldner - 2023sv - PMWC Precision Medicine World Conference
Get intro to Nicholas
Add to my network
Location
San Francisco Bay Area
People also viewed
Brewster Stanislaw
Chief Product Officer at Demandbase, Entrepreneur, Investor, Advisor
Shardule Shah, PhD, MBA
Co-founder and CEO @ Lime Therapeutics | Harvard Business School Executive Fellow | Termeer Fellow
Alicia Levey
Mutual Connections
See who you know in common with Nicholas
Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
People also viewed
Brewster Stanislaw
Chief Product Officer at Demandbase, Entrepreneur, Investor, Advisor
Shardule Shah, PhD, MBA
Co-founder and CEO @ Lime Therapeutics | Harvard Business School Executive Fellow | Termeer Fellow
Alicia Levey
Mutual Connections
See who you know in common with Nicholas